Form D · Biotechnology
BIOSCALE INC
Lexington, MA · CIK 0001270091
Offering snapshot reported Jul 8, 2013 · SEC filing
- Reported sold
- $18.8M Offering amount: $38.3M
- Investors reported
- 69 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 21, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2013 | Initial | $18,838,559 | No comparison | 69 | SEC filing |
| Mar 11, 2013 | Initial | $1,062,028 | No comparison | 25 | SEC filing |
| Feb 21, 2013 | Amendment | $3,827,004 | -$1,434,046vs Mar 6, 2012 | 62 | SEC filing |
| Mar 6, 2012 | Initial | $5,261,050 | No comparison | 37 | SEC filing |
| Jun 11, 2010 | Initial | $15,672,158 | No comparison | 42 | SEC filing |
| Jul 29, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 5, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 14, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-199127
Source: Form D, filed Jul 8, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Billings | Director |
| Isaac Cheng | Director |
| Edward Crawley | Director |
| William F. Doyle | Director |
| Bill Doyle | Director |
| Bard Geesaman | Director |
| Dr. Martin Latterich | Executive |
| Chip Leveille | Executive |
| Mark Lundstrom | Director, Executive |
| Brett Masters | Executive |
| Riccardo Pigliucci | Director |
| Somu Subramaniam | Director |
| Somu Subramanian | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 Maguire Road
Lexington, MA, 02421
Lexington, MA, 02421